Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07096141

Improving Emotional Wellbeing of University Students: Emotion Regulation

University students' psychological well-being is a growing public health concern. University life involves major psychological, social, and academic changes, increasing vulnerability to mental health issues. Group-based Dialectical Behaviour Therapy (DBT) has been shown to support student well-being effectively. However, interventions tailored to specific cultural and contextual needs are more likely to be helpful. Western-based therapy models may not fully align with non-Western populations, such as students in Türkiye.

In Türkiye, public mental health services are often limited to short psychiatric consultations, while therapy is typically accessed privately. University counselling centres offering free or low-cost therapy are therefore essential. Cost-effective interventions like group DBT may be especially valuable in these settings. To address this gap, culturally adapted DBT groups should be developed and evaluated for Turkish university students.

This study is part of the UniWELL Project (sister to UniWELL-C) and examines the effectiveness of DBT-informed emotion regulation groups for Turkish students. Any Bogazici University student aged 18+ is eligible. Exclusion criteria include severe mental illness, high risk of harm to self/others, or scoring below threshold on the Difficulties in Emotion Regulation Scale (DERS-16), as these students may require more individual support.

The study includes participation in an 8-session DBT-informed group. Participants are expected to benefit from free psychological support, guided reflection, and shared experiences with peers. The research will also contribute to the evidence base for culturally adapted interventions.

There are some risks: participants may feel overwhelmed during the sessions or while completing questionnaires. If so, support will be provided by a clinical psychology master's student and/or the group facilitator, under supervision of an experienced clinical psychologist. If a participant's risk increases, they will be referred to psychiatric services. An emergency contact will be requested to ensure safety if needed.

The study will take place at Bogazici University through the Translational Clinical Psychology Lab, in collaboration with BUREM. It is expected to run for at least one year, possibly extending up to three years. The study is partially funded by the Bogazici Scientific Research Projects Unit (20022). Dr Ayse Akan ([email protected]) is the study lead and main contact.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Bogazici University Student Guidance and Psychological Counselling Centre (BUREM), Istanbul, Turkey (Türkiye)

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Must be a Bogazici University student.
  • Must be 18 years or older.
  • Must score above the threshold on the Difficulties in Emotion Regulation Scale (DERS-16).

Exclusion criteria

  • Not Bogazici University student.
  • Has serious and severe mental illness.
  • High risk of self-harm/harm to others.
  • Scoring below the threshold of on the Difficulties in Emotion Regulation Scale (DERS-16).
  • Younger than 18 years old.

Treatment and study plan

DBT-informed Group Psychotherapy for Emotion Regulation

Behavioral

An 8-session Dialectical Behaviour Therapy informed emotion regulation psychotherapy group.

Other names: DBT, Group DBT

Primary outcomes

  1. Difficulties in Emotion Regulation Scale (DERS-16)

    Time frame: Baseline, immediately after the intervention, and follow-up 6 weeks after the completion intervention

    Difficulties in Emotion Regulation Scale (DERS-16) is a questionnaire that measures different aspects of difficulties in emotion, including emotional awareness, clarity, acceptance, impulse control, and goal-directed behavior during emotional distress. Each item is scored on a 5-point Likert scale, from 1 (almost never) to 5 (almost always), resulting in a total score range of 16 to 80. Higher scores indicate greater difficulties in emotion regulation.

Secondary outcomes

  1. Borderline Evaluation of Severity Over Times (BEST)

    Time frame: Baseline, immediately after the intervention, and follow-up 6 weeks after the completion intervention

    The Borderline Evaluation of Severity Over Times (BEST) is a tool that measures the severity and progression of thoughts, feelings, and behaviors that are typical of Borderline Personality Disorder. Each item is rated on a 5-point Likert scale, where 1 indicates none/rarely and 5 indicates almost always, resulting in a total score range between 12 and 72. Higher scores indicate more severe symptoms. The scale also provides information about positive behaviors separately.

  2. Depression Anxiety and Stress Scale (DASS-42)

    Time frame: Baseline, immediately after the intervention, and follow-up 6 weeks after the completion of the intervention

    Depression Anxiety Stress Scale (DASS-42) is a questionnaire that measures the negative emotional states depression, anxiety and stress. Each subscale is scored separately. Each item is rated on a 4-point Likert scale from 0 (did not apply to me at all) to 3 (applied to me very much or most of the time). Scores for each subscale range from 0 to 42, and the combined total scale ranges from 0 to 126. Higher scores indicate more severity. The severity is categorized into "normal", "mild", "moderate", "severe", and "extremely severe".

  3. Generalised Anxiety Disorder-7 (GAD7)

    Time frame: Baseline, immediately after the intervention, and follow-up 6 weeks after the completion of the intervention

    The Generalised Anxiety Disorder - 7 Scale (GAD7) is a questionnaire used to screen for Generalised Anxiety Disorder and assess the severity of anxiety symptoms. Each item is rated on a 4-point Likert scale from 0 (not at all) to 3 (nearly every day), resulting in a total score ranging from 0 to 21. Higher scores indicate more severity. The severity is categorized into "minimal", "mild", "moderate", and "severe".

  4. Patient Health Questionnaire (PHQ9)

    Time frame: Baseline, immediately after the intervention, and follow-up 6 weeks after the completion of the intervention

    The Patient Health Questionnaire (PHQ9) is a scale used for assessing the presence and the severity of depression. Each item is rated on a 4-point Likert scale from 0 (not at all) to 3 (nearly every day), resulting in a total score that ranges from 0 to 27. Higher scores indicate more severity of depressive symptoms. The severity is categorized into "minimal", "mild", "moderate", "moderately severe" and "severe".

  5. Outcome Rating Scale (ORS)

    Time frame: From enrollment to the end of treatment at 8 weeks

    Outcome Rating Scale (ORS) is a brief 4-item scale used for assessing the members' overall functioning in key areas: individual well-being, interpersonal relationships, social role, and overall well-being. Each item is rated on a visual analog scale from 0 to 10, resulting in a total score between 0 and 40. Higher scores indicate better overall functioning and well-being.

  6. Qualitative data

    Time frame: Up to 12 weeks following the completion of the intervention

    Participants who completed their groups will also be invited to attend a semi-structured interview for in-depth qualitative feedback when they finish the intervention. Below are the sample questions to be asked to the participants:

    • Could you tell us a little about the process (your mental health difficulties) that led you to apply to this group?
    • Were you satisfied with the group?
    • Which parts of the group were useful to you?
    • Which parts of the group need to change (what you didn't like)?
    • How was your relationship with the therapist and assistants?
    • How was your relationship with the other participants of the group?
    • What was the most important thing you learned from the group?
    • Are there any other things that stood out to you?
    • Would you recommend this group to other students with similar problems?
    • Do you think this group should be an ongoing service provided by the university?

Other outcomes

  1. Group Session Rating Scale (GSRS)

    Time frame: From enrollment to the end of treatment at 8 weeks

    Group Session Rating Scale (GSRS) is a brief 4-item scale used for assessing the members' evaluation of each session regarding the therapeutic relationship, goals and topics, approach or method, and overall experience. Each item is rated on a visual analog scale from 0 to 10, resulting in a total score between 0 and 40. Higher scores indicate more satisfaction with the group session.

  2. Feedback Form

    Time frame: Immediately after the intervention

    The client feedback form is a 4-point self-report scale with a free-text box for additional comments. It is used to gather information about participants' experiences with the group facilitator and the intervention. The form includes questions about the therapeutic process, the structure of the sessions, the therapist's approach, and whether the support was helpful.

Study contacts

Contact information is provided by the study sponsor or research team.

Ayse Akan, DClinPsych

CONTACT

[email protected]

+902123597054

Sponsors and collaborators

Lead sponsor

Bogazici University

Other

Registry information

Official study title

Improving Emotional Wellbeing of University Students Using Culturally Adapted Dialectic Behaviour Approaches in Group Settings" (UniWELL-D): Protocol of a Feasibility and Effectiveness Study

Acronym: UniWELL-D

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
Jul 31, 2025
Registry last updated
Dec 22, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.